These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 849606)

  • 1. A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro.
    Jiao H; Shen W; Ohe Y; Miura K; Tamura T; Saijo N
    Cancer Immunol Immunother; 1992; 35(6):412-6. PubMed ID: 1394344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.
    Verloes R; Atassi G; Dumont P; Kanarek L
    Br J Cancer; 1981 Feb; 43(2):201-9. PubMed ID: 7470382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytophilic antibody as an auxiliary factor in cell-mediated immunity.
    Ptak W
    Allerg Immunol (Leipz); 1973; 19(2-4):290-6. PubMed ID: 4375939
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic recognition and killing capacity of immune macrophages in mixed macrophage cultures (MMC).
    Gallily R
    Cell Immunol; 1975 Feb; 15(2):419-31. PubMed ID: 122917
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on antilymphocytic autoimmune reactions in L1210 bearing mice.
    Devlin RG; Baugh LE; McCurdy JD; Baronowsky PE
    Cell Immunol; 1975 May; 17(1):156-64. PubMed ID: 123826
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
    Nicolin A; Bini A; Franco P; Goldin A
    Cancer Chemother Rep; 1974; 58(3):325-30. PubMed ID: 4841716
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
    Lee KC; Berry D
    J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of in vitro primary immune response by L1210 cells and their culture supernatant: evidence for cytotoxic effects.
    Huget RP; Flad HD; Opitz HG
    Cell Immunol; 1977 Mar; 29(1):210-5. PubMed ID: 849606
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
    Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
    Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.